These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35241294)

  • 1. Addressing the challenges of accelerated and blast phase myeloproliferative neoplasms in 2022 and beyond.
    Saha C; Attwell L; Harrison CN; McLornan DP
    Blood Rev; 2022 Sep; 55():100947. PubMed ID: 35241294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated Phase of Myeloproliferative Neoplasms.
    Shahin OA; Chifotides HT; Bose P; Masarova L; Verstovsek S
    Acta Haematol; 2021; 144(5):484-499. PubMed ID: 33882481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated and Blast Phase Myeloproliferative Neoplasms.
    Jain T; Rampal RK
    Hematol Oncol Clin North Am; 2021 Apr; 35(2):325-335. PubMed ID: 33641872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress?
    Mahdi D; Spiers J; Rampotas A; Polverelli N; McLornan DP
    Br J Haematol; 2023 Oct; 203(2):169-181. PubMed ID: 37527977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated and blast phase myeloproliferative neoplasms.
    Saliba AN; Gangat N
    Best Pract Res Clin Haematol; 2022 Jun; 35(2):101379. PubMed ID: 36333070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN.
    Pasca S; Chifotides HT; Verstovsek S; Bose P
    Int Rev Cell Mol Biol; 2022; 366():83-124. PubMed ID: 35153007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat the blast phase of Philadelphia chromosome-negative myeloproliferative neoplasms.
    Odenike O
    Blood; 2018 Nov; 132(22):2339-2350. PubMed ID: 30333119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hitting the brakes on accelerated and blast-phase myeloproliferative neoplasms: current and emerging concepts.
    Bewersdorf JP; Rampal RK
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):218-224. PubMed ID: 36485103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
    Cherington C; Slack JL; Leis J; Adams RH; Reeder CB; Mikhael JR; Camoriano J; Noel P; Fauble V; Betcher J; Higgins MS; Gillette-Kent G; Tremblay LD; Peterson ME; Olsen JJ; Tibes R; Mesa RA
    Leuk Res; 2012 Sep; 36(9):1147-51. PubMed ID: 22578777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?
    Kundranda MN; Tibes R; Mesa RA
    Curr Hematol Malig Rep; 2012 Mar; 7(1):78-86. PubMed ID: 22170483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium.
    Mascarenhas J; Heaney ML; Najfeld V; Hexner E; Abdel-Wahab O; Rampal R; Ravandi F; Petersen B; Roboz G; Feldman E; Podoltsev N; Douer D; Levine R; Tallman M; Hoffman R;
    Leuk Res; 2012 Dec; 36(12):1500-4. PubMed ID: 22938832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It.
    Patel AA; Odenike O
    Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):303-309. PubMed ID: 36907766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Concise Update on Risk Factors, Therapy, and Outcome of Leukemic Transformation of Myeloproliferative Neoplasms.
    Mascarenhas J
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S124-9. PubMed ID: 27521308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.
    Pardanani A; Lasho TL; Finke CM; Mai M; McClure RF; Tefferi A
    Leukemia; 2010 Jun; 24(6):1146-51. PubMed ID: 20410924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options.
    Iurlo A; Cattaneo D; Gianelli U
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
    Tefferi A; Alkhateeb H; Gangat N
    Blood Cancer J; 2023 Jul; 13(1):108. PubMed ID: 37460550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms.
    Castillo Tokumori F; Al Ali N; Chan O; Sallman D; Yun S; Sweet K; Padron E; Lancet J; Komrokji R; Kuykendall AT
    Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):e521-e525. PubMed ID: 35241387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.
    Patel AA; Yoon JJ; Johnston H; Davidson MB; Shallis RM; Chen EC; Burkart M; Oh TS; Iyer SG; Madarang E; Muthiah C; Gross I; Dean R; Kassner J; Viswabandya A; Madero-Marroquin R; Rampal RK; Guru Murthy GS; Bradley T; Abaza Y; Garcia JS; Gupta V; Pettit KM; Cursio JF; Odenike O
    Blood Adv; 2024 Jul; 8(13):3468-3477. PubMed ID: 38739724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic models in the myeloproliferative neoplasms.
    Grinfeld J
    Blood Rev; 2020 Jul; 42():100713. PubMed ID: 32532453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.